0.97 g/100 ml
CH3OH)
D6016 14110-71-5 White powder C29H37NO5 481.64 192-193°C
C2149 36011-19-5 White powder C28H33NO7 495.58 206°C -25.6 (1g/100 ml MeOH @
25°C)
C8273 22144-76-9 White powder or
0.97 g/100 ml
CH3OH)
D6016 14110-71-5 White powder C29H37NO5 481.64 192-193°C
C2149 36011-19-5 White powder C28H33NO7 495.58 206°C -25.6 (1g/100 ml MeOH @
25°C)
C8273 22144-76-9 White powder or
Clone:PKB-175 P2482 Signal Transduction M y y y
205 PKB/AKT P1601 Signal Transduction P y y y
206 PKB phosphoserine 473 (pS
473) P4112 Signal Transduction P n/d y y
207 PKB phosphothreonine 308
C. (2002) Cardiac HCN channels: structure,
function, and modulation. Trends Cardiovasc Med 12(5), 206-212.
Brewster, A. L., Bernard, J. A., Gall, C. M., and Baram, T. Z. (2005) Formation of
heteromeric
C. (2002) Cardiac HCN channels: structure,
function, and modulation. Trends Cardiovasc Med 12(5), 206-212.
Brewster, A. L., Bernard, J. A., Gall, C. M., and Baram, T. Z. (2005) Formation of
heteromeric
Potential of p38-MAPK inhibitors in the treatment of ischaemic
heart disease. Pharmacol Ther. 2007;116:192-206. PMID: 17765316
15. Bertelsen M, Sanfridson A. Inflammatory pathway analysis using a high content
Applications to
Cell Growth and Cell Mediated Cytotoxicity.
Cytometry Supp. 1990; 4: 105-105. (Abstract)
192. Sorette M, Clark M: Direct In-Vivo Observations
of Partial Phagocytosis of Animal Red
M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2
M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2
M NP_002261.3 y y y
203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2
, micro pore-forming hydrogel biomaterials have
been developed that can be applied to bioprinting.206–208 For
example, a micro pore-forming bioink based on the aqueous
two-phase emulsion (ATPE) improved
, micro pore-forming hydrogel biomaterials have
been developed that can be applied to bioprinting.206–208 For
example, a micro pore-forming bioink based on the aqueous
two-phase emulsion (ATPE) improved
Cytohesin-1 C8979 M y n/d n/d
203 Cytokeratin peptide 4 C5176 M y n/d n/d
204 Cytokeratin CK5 C7785 M y n/d n/d
205 Cytokeratin peptide 7 C6417 M y n/d n/d
206 Cytokeratin 8.12 C7034 M y n/d n/d
207 Cytokeratin